{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:37:36Z","timestamp":1760985456012,"version":"3.37.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.xphs.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T12:47:41Z","timestamp":1467982061000},"page":"2437-2443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["On the Thermal Stability of the Diethylcarbamazine-Fortified Table\u00a0Salt Used in the Control of Lymphatic Filariasis"],"prefix":"10.1016","volume":"105","author":[{"given":"Sara B.","family":"Honorato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia C.P.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara S.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge S.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nubia","family":"Boechat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ellena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro P.","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.xphs.2016.06.003_bib1","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pntd.0000317","article-title":"The global programme to eliminate lymphatic filariasis: health impact after 8 years","volume":"2","author":"Ottesen","year":"2008","journal-title":"PLoS Neglec Trop D"},{"issue":"6","key":"10.1016\/j.xphs.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QCO.0b013e32833fdee5","article-title":"Elimination of lymphatic filariasis: do we have the drugs to complete the job?","volume":"23","author":"Bockarie","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.xphs.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/eri.09.36","article-title":"Current practices in the management of lymphatic filariasis","volume":"7","author":"Bockarie","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1476-5381.1950.tb01010.x","article-title":"The mode of action of Hetrazan on filarial worms","volume":"5","author":"Hawking","year":"1950","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1016\/j.xphs.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.2174\/092986706778773103","article-title":"Recent developments in search of antifilarial agents","volume":"13","author":"Tripathi","year":"2006","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2004.71.466","article-title":"Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs","volume":"71","author":"De Rochars","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.xphs.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2471\/BLT.06.034108","article-title":"Unfulfilled potential: using diethylcarbamazine-fortified salt to elimate lymphatic filariasis","volume":"85","author":"Lammie","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"11","key":"10.1016\/j.xphs.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A\u00a0review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Neglec Trop D"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib9","first-page":"CD003758","article-title":"Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis","author":"Adinarayanan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.xphs.2016.06.003_bib10","first-page":"405","article-title":"Control of Bancroftian filariasis by cooking salt medicated with diethylcarbamazine","volume":"37","author":"Hawking","year":"1967","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib11","first-page":"85","article-title":"Mass administration of DEC-medicated salt for filariasis control in the endemic population of Karaikal, south India: implementation and impact assessment","volume":"74","author":"Reddy","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"Suppl","key":"10.1016\/j.xphs.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1017\/S0031182000007150","article-title":"Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes","volume":"121","author":"Houston","year":"2000","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.xphs.2016.06.003_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4269\/ajtmh.1994.50.655","article-title":"Diethylcarbamazine salt in the control of lymphatic filariasis","volume":"50","author":"Gelband","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-011-2252-4","article-title":"Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?","volume":"109","author":"Shriram","year":"2011","journal-title":"Parasitol Res"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1010539508327032","article-title":"Clinicians' attitude on mass drug administration under the program to eliminate lymphatic filariasis: a qualitative study from Orissa, India","volume":"21","author":"Kerketta","year":"2009","journal-title":"Asia Pac J Public Health"},{"issue":"7","key":"10.1016\/j.xphs.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1179\/000349809X12459740922255","article-title":"Mass drug administration against filariasis in India: perceptions and practices in a rural community in Kerala","volume":"103","author":"Aswathy","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib17","first-page":"81","article-title":"Can southeast Asia eradicate, yaws by 2010? Some lessons from the Yaws Eradication Programme of India","volume":"20","author":"Lahariya","year":"2007","journal-title":"Natl Med J India"},{"issue":"6","key":"10.1016\/j.xphs.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2471\/BLT.06.037457","article-title":"Global eradication of polio: the case for \u201cfinishing the job\u201d","volume":"85","author":"Lahariya","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib19","first-page":"141","article-title":"Pilot experiments on mass treatment of bancroftian filariasis with medicated food or drink","volume":"37","author":"Kanda","year":"1967","journal-title":"Jpn J Exp Med"},{"issue":"7","key":"10.1016\/j.xphs.2016.06.003_bib20","doi-asserted-by":"crossref","first-page":"e2915","DOI":"10.1371\/journal.pntd.0002915","article-title":"Haiti National Program for the elimination of lymphatic filariasis\u2013a model of success in the face of adversity","volume":"8","author":"Oscar","year":"2014","journal-title":"PLoS Neglec Trop D"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib21","first-page":"1","article-title":"How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions","volume":"48","author":"Lahariya","year":"2011","journal-title":"J\u00a0Vector Dis"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-9957-2-30","article-title":"The history of the elimination of lymphatic filariasis in China","volume":"2","author":"De-Jian","year":"2013","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0001-706X(01)00163-2","article-title":"A\u00a0high performance liquid chromatographic method for the estimation of diethylcarbamazine content in medicated salt samples","volume":"80","author":"Mathew","year":"2001","journal-title":"Acta Trop"},{"issue":"6","key":"10.1016\/j.xphs.2016.06.003_bib24","first-page":"864","article-title":"Colorimetric determination of diethyl carbamazine (Hetrazan) with picric acid","volume":"61","author":"Ramachan","year":"1973","journal-title":"Indian J Med Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.06.003_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0378-4347(97)00424-6","article-title":"Specific gas chromatographic analysis of diethylcarbamazine in human plasma using solid-phase extraction","volume":"704","author":"Lee","year":"1997","journal-title":"J\u00a0Chromatogr B"},{"issue":"5","key":"10.1016\/j.xphs.2016.06.003_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0731-7085(95)01664-3","article-title":"Determination of diethylcarbamazine, an antifilarial drug, in human urine by 1H-NMR spectroscopy","volume":"14","author":"Jaroszewski","year":"1996","journal-title":"J\u00a0Pharm Biomed"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib27","doi-asserted-by":"crossref","first-page":"e1005","DOI":"10.1371\/journal.pntd.0001005","article-title":"A\u00a0low-tech analytical method for diethylcarbamazine citrate in medicated salt","volume":"5","author":"Weaver","year":"2011","journal-title":"PLoS Neglec Trop D"},{"issue":"3","key":"10.1016\/j.xphs.2016.06.003_bib28","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s10973-012-2775-7","article-title":"Study of stability and drug-excipient compatibility of diethylcarbamazine citrate","volume":"111","author":"Chaves","year":"2012","journal-title":"J\u00a0Therm Anal Calorim"},{"issue":"8","key":"10.1016\/j.xphs.2016.06.003_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1473-3099(05)70192-4","article-title":"Mass chemotherapy options to control lymphatic filariasis: a systematic review","volume":"5","author":"Tisch","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vibspec.2007.06.004","article-title":"Polymorphism in drugs investigated by low wave number Raman scattering","volume":"45","author":"Ayala","year":"2007","journal-title":"Vib Spec"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.06.003_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2006.07.023","article-title":"Solid state characterization of olanzapine polymorphs using vibrational spectroscopy","volume":"326","author":"Ayala","year":"2006","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2016.06.003_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2005.05.035","article-title":"Thermal behaviour and stability in Olanzapine","volume":"301","author":"Polla","year":"2005","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2016.06.003_bib33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jrs.1952","article-title":"Polymorphism incidence in commercial tablets of mebendazole: a vibrational spectroscopy investigation","volume":"39","author":"Ayala","year":"2008","journal-title":"J\u00a0Raman Spectrosc"},{"issue":"7","key":"10.1016\/j.xphs.2016.06.003_bib34","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1021\/cg100212q","article-title":"Triple structural transition below room temperature in the antifilarial drug diethylcarbamazine citrate","volume":"10","author":"da Silva","year":"2010","journal-title":"Cryst Growth Des"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10973-010-1015-2","article-title":"Thermal behaviour of citric acid and isomeric aconitic acids","volume":"104","author":"Wyrzykowski","year":"2010","journal-title":"J\u00a0Therm Anal Calorim"},{"key":"10.1016\/j.xphs.2016.06.003_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0040-6031(86)87081-2","article-title":"Thermal decomposition of citric acid","volume":"98","author":"Barbooti","year":"1986","journal-title":"Thermochim Acta"},{"issue":"2","key":"10.1016\/j.xphs.2016.06.003_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.1948.tb39849.x","article-title":"Some toxicological and pharmacological properties of 1-diethylcarbamoyl-4-methylpiperazine hydrochloride, hetrazan","volume":"50","author":"Harned","year":"1948","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.xphs.2016.06.003_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/jo01159a018","article-title":"Experimental chemotherapy of filariasis. IV. The preparation of derivatives of piperazine","volume":"13","author":"Stewart","year":"1948","journal-title":"J\u00a0Org Chem"},{"issue":"4","key":"10.1016\/j.xphs.2016.06.003_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1071\/CH9710771","article-title":"Thermal decomposition of citraconic anhydride","volume":"24","author":"Daly","year":"1971","journal-title":"Aust J Chem"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916414711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916414711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T21:13:55Z","timestamp":1617570835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916414711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0022354916414711"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2016.06.003","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the Thermal Stability of the Diethylcarbamazine-Fortified Table\u00a0Salt Used in the Control of Lymphatic Filariasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}